Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted carbapenems for the treatment of bacterial infections

Substituted carbapenems for the treatment of bacterial infections

US Patent 11180504 · Granted Nov 23, 2021

Estimated economic value: $242,106,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Chromane amidine monobactam compounds for the treatment of bacterial infections2024
Substituted RIG-I agonists: compositions and methods thereof2023
Substituted imidazo[1,2-c]quinazolines as A2A antagonists2022
Long-acting co-agonists of the glucagon and GLP-1 receptors2022
Substituted pyrido[4,3-b]indoles and azepino[4,5-b]indoles as inhibitors of cGAS2022
Biaryl monobactam compounds and methods of use thereof for the treatment of bact2022
Antidiabetic bicyclic compounds2022
Metallo-beta-lactamase inhibitors and methods of use thereof2021
Antidiabetic heterocyclic compounds2021
Insulin dimer-incretin conjugates2021
Glucose responsive insulin comprising a tri-valent sugar cluster for treatment o2021
Substituted N′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,2021